// App-Quantinova.ai

TCT-825 : Outcomes of Patients With and Without Hyperlipidemia Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis from the EXCEL Trial

Researchers

Presenter

  • Shmuel Chen

Principal Investigators

  • Bjorn Redfors

  • Yangbo Liu

  • Mathias Vrolix

  • Carlos Macaya

  • Ori Ben-Yehuda

  • A. Pieter Kappetein

  • Joseph Sabik

  • Patrick Serruys

  • Gregg Stone

Medical Centers

  • Imperial College, London, United Kingdom

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • St Jan Zikenhuis ZOL, Genk, Belgium

  • HOSPITAL CLINICO SAN CARLOS, MADRID, Spain

  • CRF, New York, New York, United States

  • Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York, United States

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

Locations

  • United Kingdom

  • Spain

  • Belgium

  • United States

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Left main disease

  • Dyslipidemia

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved